Dopamine DRD2/Cys311 Is Not Associated with Chronic Schizophrenia

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 67, Issue 5, 1996, Pages 483-484

  Crawford, Fiona ^a   Hoyne, Jonathan ^a   Cai, Xingang ^a   Osborne, Aaron ^a   Poston, Devin ^a   Zaglul, Jose ^a   Dajani, Nabil ^a   Walsh, Shirley ^b   Bradley, Richard ^b   Solomon, Richard ^b   Mullan, Michael ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b G Pierce Wood Memorial Hospital   (United States)

Author keywords

DRD2 receptor; Genetic association; Schizophrenia; Ser Cys 311 variant

Indexed keywords

DOPAMINE 2 RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CODON; CYSTEINE; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HUMANS; JAPAN; POINT MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; SERINE; UNITED STATES; VARIATION (GENETICS);

EID: 0029743806     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960920)67:5<483::AID-AJMG8>3.0.CO;2-L     Document Type: Article

References (8)

1. Arinami T, Itowaka M, Enguchi H, Tagaya H, Yano S, Shimuzu H, Hamaguchi H, Toru M (1994): Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343:703-704.
2. Armitage P, Berry G (1987): "Statistical Methods in Medical Research," 2nd ed. Oxford: Blackwell Scientific Publications, pp 129-130.
3. Asherson P, Williams N, Roberts E, McGuffin P, Owen M (1994): DRD2 Ser 311 polymorphism and schizophrenia. Lancet 343:1045.
4. Gejman P, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D, Blum K, Noble E, Kranzler H, O'Malley S, Hamer D, Whitsitt F, Rao P, DeLisi L, Virkkunen M, Linnoila M, Goldman D, Gershon E (1994): No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. JAMA 271:204-208.
5. Kay SR, Fiszbein A, Opler L (1987): The positive and negative syndrome scale for schizophrenia. Schizophrenia Bulletin 13:261-276.
6. Laurent C, Bodeau-Pean S, Campion D, d'Amato T, Jay M, et al, (1994): No major role for the dopamine D2 receptor Ser to Sys311 mutation in schizophrenia. Psyehiatr Genet 4:229-230.
7. Overall J, Gorham G (1962): The brief psychiatric rating scale. Psychological Reports 10:799-812.
8. Shaikh S, Collier D, Arranz M, Ball D, Gill M, Kerwin R (1994): DRD2 Ser311 polymorphism and schizophrenia. Lancet 343:1045-1046.